Sudden cardiac arrest (SCA) claims the lives of 436,000 people in the United States each year, with more than 350,000 events occurring outside the Hospital1. When an out-of-hospital arrest (OHCA) occurs, help is needed immediately. However, without a bystander nearby or medical equipment on-hand, those at risk of SCA are left without protection. To protect those at risk of SCA, Kestra Medical Technologies introduced the ASSURE® Wearable Cardioverter Defibrillator (WCD) to help deliver lifesaving care in these critical situations.
Although the startup MedTech company held deep expertise in the development of Class III therapeutic medical devices, the company sought advanced cloud and mobile application development resources to help build the next-generation digital healthcare platform it envisioned. Kestra partnered with the product team at GlobalLogic, a Hitachi Group company, to design a uniquely data-enabled, connected platform. As a result, in 2021, the ASSURE Cardiac Recovery System was introduced. The ASSURE system is a modern approach to sudden cardiac arrest protection. It includes the ASSURE WCD, the ASSURE patient app and the Kestra CareStation™ remote patient data platform, all working together as a digital healthcare system to support and protect at-risk cardiac patients.
Since launch, the system has already benefited thousands of cardiac patients.